NO964032L - Kovalente dimerer av kit-ligand og FLT-3/FLK-2-ligand - Google Patents

Kovalente dimerer av kit-ligand og FLT-3/FLK-2-ligand

Info

Publication number
NO964032L
NO964032L NO964032A NO964032A NO964032L NO 964032 L NO964032 L NO 964032L NO 964032 A NO964032 A NO 964032A NO 964032 A NO964032 A NO 964032A NO 964032 L NO964032 L NO 964032L
Authority
NO
Norway
Prior art keywords
ligand
murine
kit
protein
fusion
Prior art date
Application number
NO964032A
Other languages
English (en)
Norwegian (no)
Other versions
NO964032D0 (no
Inventor
Karl H Nocka
Robert B Lobell
Original Assignee
Cytomed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cytomed Inc filed Critical Cytomed Inc
Publication of NO964032D0 publication Critical patent/NO964032D0/no
Publication of NO964032L publication Critical patent/NO964032L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO964032A 1994-03-28 1996-09-25 Kovalente dimerer av kit-ligand og FLT-3/FLK-2-ligand NO964032L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/220,379 US5525708A (en) 1994-03-28 1994-03-28 Covalent dimer of kit ligand
PCT/US1995/003866 WO1995026199A1 (fr) 1994-03-28 1995-03-28 Dimeres covalents de kit ligand et de ligand de flt-3/flk-2

Publications (2)

Publication Number Publication Date
NO964032D0 NO964032D0 (no) 1996-09-25
NO964032L true NO964032L (no) 1996-11-28

Family

ID=22823324

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964032A NO964032L (no) 1994-03-28 1996-09-25 Kovalente dimerer av kit-ligand og FLT-3/FLK-2-ligand

Country Status (10)

Country Link
US (1) US5525708A (fr)
EP (1) EP0759767A1 (fr)
JP (1) JPH09512706A (fr)
AU (1) AU2199895A (fr)
CA (1) CA2186496A1 (fr)
FI (1) FI963900A (fr)
HU (1) HU9602682D0 (fr)
MX (1) MX9604394A (fr)
NO (1) NO964032L (fr)
WO (1) WO1995026199A1 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ307995A3 (en) 1993-05-24 1996-10-16 Immunex Corp Ligands for flt3 receptors
US5554512A (en) * 1993-05-24 1996-09-10 Immunex Corporation Ligands for flt3 receptors
US6190655B1 (en) 1993-12-03 2001-02-20 Immunex Corporation Methods of using Flt-3 ligand for exogenous gene transfer
US7294331B2 (en) * 1994-03-07 2007-11-13 Immunex Corporation Methods of using flt3-ligand in hematopoietic cell transplantation
US20020034517A1 (en) * 1995-10-04 2002-03-21 Kenneth Brasel Dendritic cell stimulatory factor
US7361330B2 (en) * 1995-10-04 2008-04-22 Immunex Corporation Methods of using flt3-ligand in the treatment of fibrosarcoma
US7150992B1 (en) 1995-10-04 2006-12-19 Innunex Corporation Methods of preparing dendritic cells with flt3-ligand and antigen
US5885962A (en) * 1996-04-05 1999-03-23 Amgen Inc. Stem cell factor analog compositions and method
KR20000022445A (ko) * 1996-07-10 2000-04-25 크리스토퍼 엘. 와이트, 스코트 지. 홀퀴스트, 스티븐 엘. 말라스카 수상돌기 세포의 활성화 방법
US6017527A (en) * 1996-07-10 2000-01-25 Immunex Corporation Activated dendritic cells and methods for their activation
JP2001527396A (ja) * 1997-04-11 2001-12-25 ジー．ディー．サール アンド カンパニー ｆｌｔ３リガンドキメラタンパク質
US20030022233A1 (en) * 1999-04-30 2003-01-30 Raymond G. Goodwin Methods of use of the taci/taci-l interaction
US20030077263A1 (en) * 1999-10-29 2003-04-24 Immunex Corporation Method of activating dendritic cells
EP1817047B1 (fr) 2004-11-05 2012-02-08 Northwestern University Utilisation de scf et de scf dans le traitement de l'ischemie cerebrale et des troubles neurologiques
US8093046B2 (en) * 2006-05-31 2012-01-10 Philadelphia Health and Education Corporation d/b/c Drexel University College of Medicine CVN-12p1: a recombinant allosteric lectin antagonist of HIV-1 envelope gp120 interactions
RU2547592C2 (ru) * 2009-07-20 2015-04-10 Нэйшнл Ченг Кунг Юниверсити ПОЛИПЕПТИДЫ, СЕЛЕКТИВНЫЕ В ОТНОШЕНИИ ИНТЕГРИНА αvβ3, КОНЪЮГИРОВАННЫЕ С ВАРИАНТОМ ЧЕЛЕВЕЧЕСКОГО СЫВОРОТОЧНОГО АЛЬБУМИНА (HSA), И ИХ ФАРМАЦЕВТИЧЕСКИЕ ПРИМЕНЕНИЯ

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873191A (en) * 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
EP1241258A3 (fr) * 1989-10-16 2003-12-10 Amgen Inc. Facteur de stimulation de cellules souches
HU220234B (hu) * 1989-10-16 2001-11-28 Amgen Inc. Eljárás stem sejtek működését befolyásoló faktorok előállitására
EP0536317A1 (fr) * 1990-06-25 1993-04-14 Immunex Corporation Facteur de croissance de mastocytes
US20030125519A1 (en) * 1990-08-27 2003-07-03 Peter Besmer Ligand for the c-kit receptor and methods of use thereof
US5199942A (en) * 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
JPH07502263A (ja) * 1991-09-13 1995-03-09 ボロン．バイオロジカルス．インコーポレイテッド 有機ホウ素化合物を利用して、動物の骨粗鬆症及びその他の病気を治療する方法
JP3750819B2 (ja) * 1992-04-23 2006-03-01 スローン − ケタリング・インスティテュート・フォー・キャンサー・リサーチ Ｃ−ｋｉｔ受容体に対するリガンド及びその使用法
US5554512A (en) * 1993-05-24 1996-09-10 Immunex Corporation Ligands for flt3 receptors

Also Published As

Publication number Publication date
FI963900A0 (fi) 1996-09-27
AU2199895A (en) 1995-10-17
WO1995026199A1 (fr) 1995-10-05
NO964032D0 (no) 1996-09-25
JPH09512706A (ja) 1997-12-22
MX9604394A (es) 1997-07-31
EP0759767A1 (fr) 1997-03-05
FI963900A (fi) 1996-11-27
US5525708A (en) 1996-06-11
HU9602682D0 (en) 1996-11-28
CA2186496A1 (fr) 1995-10-05

Similar Documents

Publication Publication Date Title
NO964032L (no) Kovalente dimerer av kit-ligand og FLT-3/FLK-2-ligand
Keski-Oja et al. Dimeric character of fibronectin, a major cell surface-associated glycoprotein
DE69725587D1 (de) Verwendung von wnt polypeptiden
Urdal et al. Affinity purification and chemical analysis of the interleukin-1 receptor.
DK25489D0 (da) Fremgangsmaade til fremstilling af en secerneret human-pdgf-receptoranalog, en secerneret biologisk aktiv peptiddimer henholdsvis en secerneret ligandbindende receptoranalog samt farmaceutisk sammensaetning omfattende samme
DE69034249D1 (de) Monoklonale Antikörper spezifisch für den zytotoxischen Lymphozyten-Reifefaktor
TW221675B (fr)
DE69637570D1 (de) Varianten des wachstumsfaktors der vaskulären endothelzellen, ihre verwendung sowie methoden für ihre herstellung
ATE167516T1 (de) Colostrum fraktion und ihre verwendung als additiv beim zellkulturmedium
DE69029856D1 (de) Verfahren, zubereitungen und anordnungen für zellzucht
ATE194169T1 (de) Beta-type ähnlicher transformierender wachstumfaktor
SI1511770T1 (sl) Glikoprotein VI-Fc fuzijski protein za zdravljenje vaskularnih bolezni
ATE294236T1 (de) Promotor der tie rezeptor protein kinase
YU78194A (sh) Dna sastav protein kompleksa i postupak za dobijanje rekombinovanog protein kompleksa
DE3650088D1 (de) Inhibin und dessen reinigung.
DE68928710D1 (de) T-Zellen-Wachstumsfaktor
MX9203879A (es) Muteina de il-6 con cisteina parcialmente suprimida.
TR199802584T2 (xx) Denat�re proteinin aktive edilmesi i�in y�ntem.
ATE124539T1 (de) Immunogen und seine verwendung zur gewinnung von antikörpern gegen hba1c.
Waterhouse et al. Collagen synthesis by murine bone marrow cell culture
DE69533905D1 (de) Interferon alpha/beta bindendes Protein, seine Herstellung und Anwendung
DE69633918D1 (de) Mutantes hämoglobin mit niedriger affinität für sauerstoff
ATE421886T1 (de) Produktion von blutzellen mittels aktivierung von cd163
Levesque et al. Evidence for two functionally different fibrinogen receptors on hemopoietic cells: The glycoprotein IIb–IIIa and the mitogenic fibrinogen receptor
WO2001040475A3 (fr) Proteines heme hemat-hs et hemat-bs; utilisation en medecine et microcapteurs